Clinical trials
Growth Disorders clinical trials
Below are recruiting growth disorders clinical trials, each written for real people, not researchers. We’re tracking 28 recruiting studies, each written for real people, not researchers, below.
Recruiting studies
- NCT03283852Recruiting
Genetic study for certain childhood hormone and development disorders
This study looks for new genetic causes of certain “development disorders” that involve hormone problems and how the body develops at puberty. It may help families understand the root cause, which can guide future care and testing.
ParisAges Any age - NCT06037473Recruiting
PEG growth hormone for short stature in children
This trial tests if a long-acting growth hormone (PEGylated GH) helps children with various causes of short stature grow taller. It may be an option if your child has a condition like growth hormone deficiency, Turner syndrome, or idiopathic short stature.
Beijing, Beijing MunicipalityAges Up to 18 years - NCT04685746Recruiting
Testing how balance and motion affect child development
This study looks at how the vestibular system (your balance and motion sensing) is involved in children’s thinking and movement. It compares typically developing children with children who have balance-related (vestibular) problems or certain neurodevelopmental conditions to understand what to expect and how development may differ.
GhentAges 6–13 - NCT03072537Recruiting
Growth monitoring using a doctor-based patient network
This study sets up a network to regularly track children’s growth based on routine doctor or pediatric visits. It may help researchers understand growth patterns and improve how growth is monitored over time.
Leipzig, SaxonyAges Up to 18 years - NCT07225153Recruiting
Goat milk formula vs. undiluted goat milk for infant growth
This trial tests whether a goat milk-based formula helps infants who cannot breastfeed grow as well as those who drink undiluted goat milk. It focuses on babies living in the Matiari District whose families have access to goat milk.
Matiāri, SindhAges 2 months–2 months - NCT07221851RecruitingPhase 3
Weekly vs daily growth hormone for short stature in children
This trial tests a weekly growth hormone injection (lonapegsomatropin) compared to the standard daily growth hormone shot in children with short stature due to certain conditions. It aims to see if the weekly shot works as well or better and is safe.
Palo Alto, CaliforniaAges 2–17 - NCT04294368Recruiting
Fortifying donor breast milk for very premature babies
This study tests whether adding extra nutrition (fortifying) to donated breast milk helps very premature infants grow better and safely. You might be offered a fortified donor milk feeding plan if your baby meets the timing and medical criteria.
New York, New YorkAges 1 day–3 weeks - NCT05929807Enrolling by invitationPhase 2/Phase 3
Weekly injection study for children with achondroplasia
This trial looks at how safe and effective weekly under-the-skin (subcutaneous) TransCon CNP is for children and teens with achondroplasia over the long term. You may be considered if your child has already finished a previous TransCon CNP study and can follow weekly injection and follow-up visits.
Little Rock, ArkansasAges 3–15 - NCT07020546Recruiting
Ovarian PRP Injections for Better Embryo Quality
This trial tests whether injecting platelet-rich plasma (PRP) into your ovaries can improve the quality of your embryos. You will go through two IVF cycles, and the treatment aims to help women with low embryo quality get better results.
New York, New YorkAges 18–47 - NCT06662045Recruiting
Iron deficiency and child brain development study
This study looks at whether iron deficiency anemia affects how babies and toddlers (6 to 24 months old) develop their thinking, learning, and behavior. It compares children who have iron-deficiency anemia with those who do not, to help doctors understand the impact on early brain development.
Shenzhen, China/GuangdongAges 6 months–6 years - NCT02769975Recruiting
Check children and teens with hormone and metabolism problems
This study evaluates children (and sometimes relatives) who may have hormone (endocrine) or metabolism-related conditions. It helps doctors better understand these problems by doing a clinical evaluation.
Bethesda, MarylandAges 3 months–100 years - NCT05604846Recruiting
Probiotic drops for very preterm babies in Scandinavia
This trial studies whether giving probiotic supplements to extremely preterm newborns helps improve health outcomes. It’s meant for babies born very early, and the results could help guide safer early nutrition and care.
Solna, Stockholm CountyAges 5 months–6 months - NCT07038239Recruiting
MORC2 gene mutation study for nerve and brain conditions
This study looks at how changes in the MORC2 gene relate to nerve or brain development problems. It may help doctors better understand these conditions and improve care.
BesançonAges 4 years+ - NCT06444503Recruiting
A study collecting samples from children with bone problems
This study collects blood and tissue samples from children with bone or growth plate problems to build a research database. It aims to better understand these conditions and may help improve future treatments.
ToulouseAges Up to 99 years - NCT07263490Recruiting
Pre-eclampsia Risk in Egg Recipients Study
This study looks at whether women who become pregnant after receiving donated eggs have a higher risk of developing pre-eclampsia (a serious blood pressure condition) during pregnancy. It aims to understand risks so doctors can better support pregnant women.
CopenhagenAges 18 years+ - NCT07004283Enrolling by invitation
Fetal MRI reference ranges for normal brain development
This study uses fetal MRI scans from a large group of healthy pregnancies to create standard growth charts for brain measurements. This helps doctors better understand normal fetal brain development.
Guangzhou, GuangdongAges 18 years+ - NCT05144035RecruitingPhase 4
Early growth-hormone treatment for small baby’s brain development
This study tests whether starting a growth hormone treatment early helps a baby’s thinking and learning development. It is for babies who are small for their gestational age and show delays on a developmental screening test.
Wuhan, WuhanAges 6 months–2 years - NCT02910180Recruiting
Biobank study of genetic and metabolic data in brain blood vessel disease
This study collects genetic and other health information from people with brain blood vessel (cerebrovascular) problems. It aims to help researchers understand causes and patterns that could lead to better care in the future.
Los Angeles, CaliforniaAges 18 years+ - NCT06395467Recruiting
Integrated treatment for teens with substance use disorder
This trial tests a treatment program for teens and young adults with substance use disorders. It includes family members and is designed to support recovery and personal growth.
Farmington, ConnecticutAges 14–21 - NCT07312227Recruiting
Pregnancy at high altitude study
This study follows pregnant women living at high altitude in Bolivia to understand how pregnancy differs from those at sea level. It may help improve care for mothers and babies in high-altitude regions.
Boston, MassachusettsAges 18–45 - NCT07383467Recruiting
Single session help for teens with anxiety or depression
This trial offers a one-time digital self-help program for Hong Kong teens aged 12 to 17 who feel anxious or down. It aims to see if a single session can make a difference.
Hong KongAges 12–17 - NCT07075276Recruiting
Comparing a new growth factor treatment to standard care for jaw joint pain
This study tests a new treatment for a common jaw joint problem called disc displacement. It compares a concentrated growth factor from your own blood to standard care to see which helps more with pain and jaw movement.
Damietta, New DamiettaAges 18–45 - NCT03338387Enrolling by invitationPhase 2
Test effects of gut hormones in bulimia
This trial studies how growth-related and gut hormones affect ghrelin, a hunger-related hormone, in people with bulimia. It may help researchers understand the body changes behind bulimia and how hormones and appetite signals work.
Ages 18–30 - NCT06115122Recruiting
PEPPI Study: Finding early signs of placental problems in pregnancy
This study looks at blood markers to find women at risk for placental problems during pregnancy. It involves blood tests in early and late pregnancy, and at birth, to see how iron levels and other factors affect the placenta and baby's health.
OuluAges Any age
Hear when a new Growth Disorders trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.
Common questions
- Are there clinical trials for growth disorders?
- Yes. Clin2 currently lists 28 recruiting growth disorders studies from the U.S. registry, each rewritten for real people, not researchers, so you can see what it’s testing and who it’s for.
- How do I know if I qualify for a growth disorders trial?
- Each study lists its eligibility criteria — rules about age, diagnosis, and prior treatments. On every Clin2 trial page we explain these in words written for real people and offer a short, optional pre-screen for a fit read. The study team makes the final decision.
- Does it cost anything to join a growth disorders trial?
- Using Clin2 is always free. Many trials cover the cost of the study treatment and related visits; some reimburse travel. The study team explains exactly what’s covered before you decide.
Related conditions
Clin2 helps you find and understand clinical trials and does not provide medical advice. Study data comes from ClinicalTrials.gov. Talk with your doctor about whether a specific trial is right for you.